https://doi.org/10.55788/60f1256c
Recent findings – predominantly based on results from animal studies – on how sugar and fat interact with the brain were reviewed by Prof. Susanne la Fleur (University of Amsterdam, the Netherlands) [1]. Using experimental free-choice diet conditions, where rats are fed with different types of chow (normal, high-fat [HF], high-sugar [HS], high-fat and high-sugar [HFHS]), Prof. la Fleur showed that both HF and HFHS diets initially increased caloric intake. However, after 4 weeks, caloric intake only continued to be elevated in animals on a HFHS diet and was not adjusted to becoming obese. In contrast, animals on a HS diet normalised their caloric intake, although shifting to an unhealthier (i.e. more sugar-containing) diet [2]. Animals on a HFHS diet, in contrast to animals on a HF or HS diet, were also highly motivated to work for a sugar reward [3].
More recent experiments showed that giving animals only a sugar bolus in the morning increased fat intake during the rest of the day. The observed effect could be mimicked by infusion of the µ-opioid receptor agonist DAMGO ([D-Ala2, N-MePhe4, Gly-ol]-enkephalin) into the nucleus accumbens of the animals [4], indicating that the nucleus accumbens plays a role in the central effects of opioids on glucose metabolism. This highlights the possibility of using nucleus accumbens μ-opioid receptors as a therapeutic target to enhance the counter-regulatory response, according to Prof. la Fleur.
In addition, it has been shown that glutamatergic lateral hypothalamus (LH) neurons are capable of discriminating sucrose from water and sucralose, a low-calory sweetener. While water and sucralose activate the LHglut receptors (and decrease dopamine output), sucrose does not. However, consumption of a HF diet does disrupt this calorie detection and LH activation. In animals on a HF diet, both water and sucrose activated the LHglut receptors, while sucralose did not (anymore) and probably is rewarding by increasing the dopamine output [5].
- La Fleur SE, et al. How junk food affects reward brain regions and drives hyperphagia. Abstract S01.03, ECNP Congress 2022, 15–18 October, Vienna, Austria.
- La Fleur SE, et al. Int J Obes (Lond). 2011;35:595–604.
- Slomp M, et al. J Neuroendocrinol. 2019;31:e12718.
- Koekkoek LL, et al. J Neuroendocrinol. 2021;33:e13036.
- Koekkoek LL, et al. FASEB Journal. 2021;35:e21804.
Copyright ©2022 Medicom Medical Publishers
Posted on
Previous Article
« Diabetes not related to abnormal biomarkers of Alzheimer’s disease Next Article
Reproductive state matters when looking at the female brain and drug treatment effects »
« Diabetes not related to abnormal biomarkers of Alzheimer’s disease Next Article
Reproductive state matters when looking at the female brain and drug treatment effects »
Table of Contents: ECNP 2022
Featured articles
Letter from the Editor
New Medications
Zuranolone shows rapid-acting efficacy in postpartum depression
Probiotics could reduce perceived stress
KarXT is effective in schizophrenic patients experiencing acute psychosis
Low-dose ulipristal acetate is an effective treatment for PMDD
New Findings
Endogenous oxytocin release helps the mind to deal with pain
Nitric oxide synthase genetic variant is a risk factor for suicidal behaviour
Early-life gut microbiota depletion changes brain morphology and behaviour
Digital Technology
Treating intrusive memories after trauma in healthcare workers using Tetris
VR exposure as effective as in vivo exposure for phobia
Efficacy of smartphone-based treatment of bipolar disorders not (yet) validated
Psilocybin
Mode of action of psilocybin
Fast and sustained effect of 2 administrations of psilocybin on depression
Antidepressant properties of psilocybin might be related to changes in sleep
Peripartum Neurobiology
Both sex hormones and serotonin play a role in peripartum mental health
Child loss induces short- and long-term neurobiological changes
Reproductive state matters when looking at the female brain and drug treatment effects
Miscellaneous
Different brain responses to fat and/or sugar
Diabetes not related to abnormal biomarkers of Alzheimer’s disease
Oxytocin treatment induces long-lasting neurobiological adaptations in autism
Related Articles
November 26, 2021
Letter from the Editor
November 26, 2021
Alcohol consumption during lockdown
November 26, 2021
BDNF/TrkB pathway promising alternative for new antidepressants
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com